반응 #1833219
ord-57d540e011964362ae5e4b8522152bf3
반응 방정식
반응물
시약
반응 조건
후처리
- 1workup.STIRRINGthe mixture was stirred for 2 h at −75° C
- 2workup.STIRRINGstirring
- 3workup.WAITwas continued for 1.5 h
- 4세척The ether phase was washed with saturated NaCl (10 mL)
- 5건조dried (Na2SO4)
- 6기타evaporated under vacuum
- 7기타The residue was purified by chromatography on silica with hexane
- 8기타repurified by reverse-phase
실험 절차
2,2,6,6-Tetramethylpiperidine (2.1 mL, 1.8 g, 12 mmol) was dissolved in dry tetrahydrofuran (15 mL), cooled to −75° C. and treated with n-butyllithium (n-BuLi, 2.5 M; 4.8 mL, 12 mmol), and the mixture was stirred for 30 min at −75° C. 5-Bromo-2,2-difluorobenzo[d][1,3]dioxole (2.0 g, 8.4 mmol) was added, and the mixture was stirred for 2 h at −75° C. 1,1,2-Trichloro-1,2,2-trifluoroethane (2.4 mL, 3.8 g, 20 mmol) was added and stirring was continued for 1.5 h. Saturated NH4Cl (10 mL) was added, and the mixture was shaken with diethyl ether (30 mL) and water (20 mL). The ether phase was washed with saturated NaCl (10 mL), dried (Na2SO4) and evaporated under vacuum. The residue was purified by chromatography on silica with hexane and then repurified by reverse-phase HPLC using 75% acetonitrile to give the title compound as a clear liquid (640 mg, 28%): 1H NMR (400 MHz, CDCl3) δ 7.38 (dd, J=8.5, 5.1 Hz, 1H), 6.90 (dd, J=9.0, 4.7 Hz, 1H); EIMS m/z 332.